Table 1.

Study design schedule

Period	Screening	Baseline	Intervention	COH
Week (W)		W0	W12	W14
Informed consent	×
Eligibility	×
Demography and medical history	×
AFC		×	×
Serum level of AMH		×	×
Basal serum levels of FSH, LH, and E2		×	×
Score of SAS		×	×
Number of retrieved oocytes				×
Number of fertilized oocytes				×
Number of cleavage				×
Number of available embryos				×
Number of high-quality embryos				×
AEs		×	×	×
Compliance		×	×	×

AFC antral follicle count, AMH anti-Müllerian hormone, FSH follicle-stimulating hormone, LH luteinizing hormone, E2 estradiol, SAS self-rating anxiety scale, AEs adverse events